Pizotifen, >=98% (HPLC)

Pizotifen, >=98% (HPLC)

Biochem/physiol Actions

Pizotifen is a serotonin antagonist acting mainly at the 5-HT1, 5-HT2A and 5HT2C receptors with some antihistamine activity. It is used for the prevention of vascular headache including migraine and cluster headache.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3573292 Pizotifen, >=98% (HPLC) 100 FIADGNVRKBPQEU-UHFFFAOYSA-N 1S/C19H21NS/c1-20-11-8-15(9-12-20)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-21-18/h2-5,10,13H,6-9,11-12H2,1H3 SIGMA-ALDRICH DMSO: ≥8 mg/mL powder ≥98% (HPLC)
£113.94 (exc VAT) per 10MG
-
+
3573293 Pizotifen, >=98% (HPLC) 100 FIADGNVRKBPQEU-UHFFFAOYSA-N 1S/C19H21NS/c1-20-11-8-15(9-12-20)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-21-18/h2-5,10,13H,6-9,11-12H2,1H3 SIGMA-ALDRICH DMSO: ≥8 mg/mL powder ≥98% (HPLC)
£451.29 (exc VAT) per 50MG
-
+